NXPL:NASDAQNextPlat Corp analysis
Data as of Oct 17, 2026 - not real-time
- Latest price
- $9.50
- Risk: high
- 9/10High risk
Summary
The moving-average structure behind NextPlat Corp is bullish at $9.50, with short-term averages leading the long-term ones. Over a rolling month the price has gained 1.3%. Relative strength is 59.2 — neutral — and the MACD signal is bullish. The recent range runs from support at $8.50 up to resistance at $9.86.
On valuation the read is undervalued — earnings multiple of 15.6 versus a 30.0 sector average, below the peer group. Sell-side targets cluster 26.3% above the current quote. Revenue is contracting at 10.3% on a -16.4% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 41.8%, a beta of 1.76 and a maximum drawdown of 62.2%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 86 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 2 out of 10.
On valuation the read is undervalued — earnings multiple of 15.6 versus a 30.0 sector average, below the peer group. Sell-side targets cluster 26.3% above the current quote. Revenue is contracting at 10.3% on a -16.4% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 41.8%, a beta of 1.76 and a maximum drawdown of 62.2%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 86 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 2 out of 10.
Top market events
- NextPlat Corp NASDAQ: NXPL "NextPlat" or the "Company" , a global consumer products and services company providing...
- MarketScreener12dNextPlat Corp completed the acquisition of Scotts Pharmacy, LLC from Ron G.
- MarketScreener11dNextPlat Completes Pensacola-Area Acquisition of Profitable Pharmacy, Accelerating Continued...
Market outlook
Short term
< 1 yearPositive
Model confidence5/105 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 6.70
- MACD momentum is positive
Medium term
1–3 yearsPositive
Model confidence4/104 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- P/E of 15.6 versus sector average of 30.0
- Trading above the 200-day average of 6.70
Long term
> 3 yearsNeutral
Model confidence2/102 out of 10
Key factors
- P/E of 15.6 versus sector average of 30.0
- Negative profit margin of -16.4%
- Analyst targets imply +26.3% versus the current price
Key metrics
Financial health
Revenue Growth-10.30%
Profit Margin-16.35%
P/E Ratio15.6
ROE-39.95%
ROA-12.70%
Debt/Equity9.58
P/B Ratio1.6
Op. Cash Flow$-4528000
Free Cash Flow$-140875
Industry P/E30.0
Technical analysis
TrendBullish
RSI59.2
Support$8.50
Resistance$9.86
MA 20$9.10
MA 50$8.83
MA 200$6.70
MACDBullish
VolumeIncreasing
Fear & Greed Index85.73
Valuation
Target Price$12.00
Upside/Downside26.32%
GradeUndervalued
TypeBlend
Risk assessment
Beta1.76
Volatility41.76%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.